B
Bharat N. Nathwani
Researcher at City of Hope National Medical Center
Publications - 160
Citations - 11814
Bharat N. Nathwani is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Lymphoma & Follicular lymphoma. The author has an hindex of 51, co-authored 160 publications receiving 11422 citations. Previous affiliations of Bharat N. Nathwani include University of Kiel & Fukuoka University.
Papers
More filters
A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project
James R. Anderson,James O. Armitage,Françoise Berger,F Cavalli,WC Chan,J Close,B Coiffier,J Connors,J Diebold,Randy D. Gascoyne,N Harris,W Hiddemann,Fcs Ho,P Jacobs,Rhs Liang,TA Lister,Kenneth A. MacLennan,HK Muller-Hermelink,Bharat N. Nathwani,A Norton,G Ott,E Pedrinis,Pooja Roy,A Schauer,D. D. Weisenburger +24 more
Journal ArticleDOI
Toward normative expert systems: Part I. The Pathfinder project.
TL;DR: This article describes Pathfinder and research in uncertain-reasoning paradigms that was stimulated by the development of the program, and describes experimental and theoretical results that directed the authors to return to reasoning methods based in probability and decision theory.
Journal ArticleDOI
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project
Thomas Rüdiger,Dennis D. Weisenburger,James R. Anderson,James O. Armitage,Jacques Diebold,Kenneth A. MacLennan,Bharat N. Nathwani,Fred Ullrich,Hans Konrad Müller-Hermelink +8 more
TL;DR: PTCLs can be diagnosed reliably by experienced hematopathologists, but immunophenotyping is absolutely necessary, and an increased ability to distinguish T-lymphocyte subsets is needed in order to better subclassify the P TCLs for therapeutic and prognostic purposes.
Journal ArticleDOI
Malignant lymphoma, lymphoblastic
TL;DR: The observations indicate that nuclear convolutions are helpful but not essential for the recognition of a clinicopathologic entity which is histologically and cytologically characterized by 1) the immaturity of the lymphoid cells indistinguishable from the lymphoblasts and prolymphocytes of ALL and 2) a high mitotic index.
Journal ArticleDOI
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.
Eli Zuckerman,Tsila Zuckerman,Alexandra M. Levine,Dan Douer,Karen Gutekunst,Masashi Mizokami,Dajuan G. Qian,Milind M. Velankar,Bharat N. Nathwani,Tse-Ling Fong +9 more
TL;DR: The prevalence of HCV infection among patients with B-cell non-Hodgkin lymphoma in the United States, a controlled study of a large cohort of patients, was determined.